August 5, 2018 – By Beth Macy
In 2000, a doctor in the tiny town of St. Charles, Va., began writing alarmed letters to Purdue Pharma, the manufacturer of OxyContin. The drug had come to market four years earlier and Art Van Zee had watched it ravage the state’s poorest county, where he’d practiced medicine for nearly a quarter-century. Older patients were showing up at his office with abscesses from injecting crushed-up pills. Nearly a quarter of the juniors at a local high school had reported trying the drug. Late one night, Van Zee was summoned to the hospital where a teenage girl he knew — he could still remember immunizing her as an infant — had arrived in the throes of an overdose. Van Zee begged Purdue to investigate what was happening in Lee County and elsewhere. People were starting to die. “My fear is that these are sentinel areas, just as San Francisco and New York were in the early years of H.I.V.,” he wrote.
EMR MATTERS – October 2024 - The challenge is that many in the behavioral health…
TOO LITTLE, TOO LATE? – Dec. 19, 2024 - Assembly Bill 56 (AB 56) proposes…
AND STOPPED DIGGING – Dec. 4, 2024 - In a new interview with The Times,…
NOT JUST IN PENCILS – Dec. 8, 2024 - Americans born before 1966 experienced “significantly…
AS SUCCESSFUL AS EVER – Dec. 3, 2024 - Family Affair actor Johnny Whitaker looked…
ALANON Plus – Dec. 7, 2024 - A high percentage of treatment failures occur due…